Metabolism and Exercise

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Open Access Policy

Editorial Board

Publication Ethics

Editorial Policies

Indexing and Abstracting

Peer Review Process

Related Links

FAQ

News

Social Networks

Guide for Authors

Forms

Publons Membership and Review Guide

referees list

referees list

The Effect of Six Weeks of Chromium Supplementation and Exercise-snacking on Patients With Non-alcoholic Fatty Liver Disease

Document Type : Research Paper I Open Access I Released under (CC BY-NC) license

Authors

1 Department of Sport Sciences, Faculty of Social Sciences, Imam Khomeini International University, Qazvin, Iran

2 Imamkhomeini International University

3 Department of Internal Medicine, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Abstract

Introduction: Non-alcoholic fatty liver disease is a chronic liver condition that can be caused by a lack of physical activity and a decrease in cardiopulmonary function. Improving lifestyle and increasing physical activity can be effective in ameliorating the condition. Chromium supplementation has been found to be effective in improving the health of individuals with obesity, diabetes, and insulin resistance.
Objective: The aim of this study was to investigate the impact of a six-week exercise snacking program and chromium supplementation on patients with non-alcoholic fatty liver disease.
Methods: In this study, 30 participants with fatty liver grade 1, 2, or 3 were randomly divided into four groups: exercise and chromium (N=8), chromium (N=8), exercise (N=7), and control (N=7). Measurements were taken for ALT and AST levels, triglycerides, body weight, age, waist circumference, and sonogram diagnosis.
Findings: The results showed a significant decrease in fatty liver grade in both the exercise and chromium group (P=0.02) and the exercise group (P=0.01). Additionally, there was a significant decrease in ALT levels in the exercise and chromium group (P=0.001) after six weeks. These findings suggest that exercise snacking, either alone or with chromium supplementation, can be effective in ameliorating non-alcoholic fatty liver disease.
Conclusion: This study provides support for the use of exercise snacking, either alone or with chromium supplementation, as an effective treatment for non-alcoholic fatty liver disease. These findings suggest that physical activity, in the form of exercise snacking, can be a suitable intervention for patients with NAFLD.

Keywords

Main Subjects

References

  1. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nature Reviews Gastroenterology & Hepatology. 2013;10(11):656-65.

    1. 2. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20.
    2. 3. Shen K, Singh AD, Modaresi Esfeh J, Wakim-Fleming J. Therapies for non-alcoholic fatty liver disease: A 2022 update. World J Hepatol. 2022;14(9):1718-29.
    3. 4. Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2019;69(6):2672-82.
    4. 5. Parastesh M, Saremi A, Ebadianejad M. Effect of Chromium Picolinate Supplementation Combined With Resistance Training on Liver Enzymes Levels and Insulin Resistance in Patients With Type 2 Diabetes. complementary Medicine Journal. 2019;9(3):3792-803.
    5. 6. Jourkesh M, Ebadi H. Effect of Six Weeks Endurance, Resistance and Combined Training on Liver ALT and AST in The Liver of Ovariectomized Rat. Journal of Applied Health Studies in Sport Physiology. 2019;6(1):78-85.
    6. 7. Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut. 2009;58(9):1281-8.
    7. 8. Pälve KS, Pahkala K, Suomela E, Aatola H, Hulkkonen J, Juonala M, et al. Cardiorespiratory Fitness and Risk of Fatty Liver: The Young Finns Study. Med Sci Sports Exerc. 2017;49(9):1834-41.
    8. 9. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459-71.
    9. 10. Stine JG, Soriano C, Schreibman I, Rivas G, Hummer B, Yoo E, et al. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2021;66(10):3604-11.
    10. 11. Wolin KY, Bennett GG, McNeill LH, Sorensen G, Emmons KM. Low discretionary time as a barrier to physical activity and intervention uptake. Am J Health Behav. 2008;32(6):563-9.
    11. 12. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124-31.
    12. 13. Lewicki S, Zdanowski R, Krzyżowska M, Lewicka A, Dębski B, Niemcewicz M, et al. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Ann Agric Environ Med. 2014;21(2):331-5.
    13. 14. Rajendran K, Manikandan S, Nair LD, Karuthodiyil R, Vijayarajan N, Gnanasekar R, et al. Serum Chromium Levels in Type 2 Diabetic Patients and Its Association with Glycaemic Control. J Clin Diagn Res. 2015;9(11):Oc05-8.
    14. 15. Chen S, Zhou L, Guo Q, Fang C, Wang M, Peng X, et al. Association of plasma chromium with metabolic syndrome among Chinese adults: a case-control study. Nutr J. 2020;19(1):107.
    15. 16. Heidari Seyedmahalle M, Haghpanah Jahromi F, Akbarzadeh M, Sohrabi Z. Effect of Chromium Supplementation on Body Weight and Body Fat: A Systematic Review of Randomized, Placebo-controlled Trials. International Journal of Nutrition Sciences. 2022;7(3):131-7.
    16. 17. Gray B, Muhlhausler BS, Davies PS, Vitetta L. Liver enzymes but not free fatty acid levels predict markers of insulin sensitivity in overweight and obese, nondiabetic adults. Nutr Res. 2013;33(10):781-8.
    17. 18. Thorp A, Stine JG. Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep. 2020;19(4):402-11.
    18. 19. Hamasaki H. Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease. Medicines. 2019;6(3):83.
    19. 20. Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, Soliman GS. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. Medicine (Baltimore). 2019;98(12):e14918.
    20. 21. Iraji H, Minasian V, Kelishadi R. Effect of HIIT exercises on liver fat, liver Enzymes, and insulin resistance in children and adolescents with non-alcoholic fatty liver. Pejouhesh dar Pezeshki (Research in Medicine). 2021; 45(1):1-7.
    21. 22. Glass OK, Radia A, Kraus WE, Abdelmalek MF. Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease. Journal of Functional Morphology and Kinesiology. 2017; 2(4):35.
    22. 23. Logan GR, Harris N, Duncan S, Schofield G. A review of adolescent high-intensity interval training. Sports Med. 2014; 44(8):1071-85.
    23. 24. Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology. 2013; 58(4):1287-95.
    24. 25. Keating SE, Hackett DA, Parker HM, Way KL, O'Connor HT, Sainsbury A, et al. Effect of resistance training on liver fat and visceral adiposity in adults with obesity: A randomized controlled trial. Hepatol Res. 2017;47(7):622-31.
    25. 26. Sargeant JA, Bawden S, Aithal GP, Simpson EJ, Macdonald IA, Turner MC, et al. Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease. Eur J Appl Physiol. 2018; 118(4):817-28.
    26. 27. MacLean C, Dillon J, Babraj JA, Vollaard NB. The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease. Phys Sportsmed. 2018; 46(1):87-92.
    27. 28. Reljic D, Konturek PC, Herrmann HJ, Siebler J, Neurath MF, Zopf Y. Very low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome. J Physiol Pharmacol. 2021; 72(6).
    28. 29. Fakhri S, Fakhri F, Shakeryan S, Alizaded A. Effect of Six Weeks of High Intensity Interval Training with Nano-curcumin Supplementation on Serum Levels of Hepatic Enzymes in Overweight Female Students: A Clinical Trial Study. Journal of Gorgan University of Medical Sciences. 2021; 23(3):16-23.
    29. Dadrass A, Mohammadzadeh Salamat K, Hamidi K, Azizbeigi K. Effects of vitamin D supplementation and resistance training on insulin resistance, lipid profile and body fat percentage in T2D men with vitamin D deficiency. Scientific Journal of Kurdistan University of Medical Sciences. 2018; 23(2):1-11.

     

Metabolism and Exercise
Volume 14, Issue 1
May 2024
Pages 1-14
Files
History
  • Receive Date: 10 July 2023
  • Revise Date: 06 September 2023
  • Accept Date: 15 November 2023
Share
How to cite
Statistics